Philips HeartNavigator cleared by FDA, gets first U.S. installation

Dave Pearson | January 03, 2012 | Health Exec | Digital Transformation

Philips Healthcare is bringing its HeartNavigator interventional imaging tool to the U.S.

The device, which is used for procedural planning and image guidance for minimally invasive heart valve replacements, saw its first U.S. installation at Medical City Dallas Hospital, added North Andover, Mass.-based Philips.

The company introduced the technology in Europe earlier in 2011 and received FDA clearance to sell it stateside.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Cardiovascular Business

Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Philips HeartNavigator cleared by FDA, gets first U.S. installation

Related Content

Around the web